FDA Approves Interchangeable Designation of Biosimilar Adalimumab-afzb
Results demonstrated comparable safety, immunogenicity, and pharmacokinetics between adalimumab-afzb and the reference product.
Source: hcplive.com
Roy Fleischmann News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Roy Fleischmann. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Roy Fleischmann Today - Breaking & Trending Today
FDA OKs Ninth Humira Biosimilar, With Interchangeability
The drug, adalimumab-afzb (Abrilada), is the second adalimumab biosimilar approved with interchangeability status. It will be available later this month.
Source: medscape.com
Transcutaneous VNS on the Ear Ineffective in RA Treatment
Experts say that these negative findings do not imply that other VNS therapies will be unsuccessful.
Source: medscape.com
Those Studies Backing Vagus Nerve Stimulation for RA? Umm...
Randomized trial gives hopes for novel treatment a cold shower
Source: medpagetoday.com
Rheumatology Month in Review: June 2023
The rheumatology month in review features studies reporting increased depression rates among patients with autoimmune disease, interventions designed to decrease chronic pain symptoms in fibromyalgia, and highlights from EULAR 2023.
Source: hcplive.com